At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
topical 0.05% Clobetasol propionate ointment +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation Following Q-switched Nd:YAG 532 nm Laser for Treatment of Facial Lentigines - A Pilot Study
In Brief
A clinical study evaluating topical 0.05% Clobetasol propionate ointment and Q switched Nd:YAG laser 532 nm for Lentigines and Post Inflammatory Hyperpigmentation. Completed, enrolled 21 participants across 1 site.
Detailed Summary
To investigate the benefit of the application of topical high potency steroid on the incidence of post inflammatory hyperpigmentation after laser treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLentigines, Post Inflammatory Hyperpigmentation
CountriesThailand
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartFeb 2015
First PostedJul 2015
Primary CompletionMay 2016
TodayJul 2026
First PostedJul 8, 2015
Enrollment StartFeb 1, 2015
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.0 years ago
Interventions
topical 0.05% Clobetasol propionate ointmentdrug
Apply only on the treated area twice a day as mentions
Q switched Nd:YAG laser 532 nmdevice
Treatment of facial lentigines. The energy using depends on the endpoint of immediate whitening of the lesions.